Congenital adrenal hyperplasia: Treatment and outcomes

M Kamoun, MM Feki, MH Sfar… - Indian Journal of …, 2013 - journals.lww.com
Congenital adrenal hyperplasia (CAH) describes a group of autosomal recessive disorders
where there is impairment of cortisol biosynthesis. CAH due to 21-hydroxylase deficiency …

Adult consequences of congenital adrenal hyperplasia

W Arlt, N Krone - Hormone research, 2007 - karger.com
Background: Congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency
accounts for 95% of all CAH cases and is one the most common inborn metabolic disorders …

Clinical outcomes in the management of congenital adrenal hyperplasia

H Falhammar, M Thorén - Endocrine, 2012 - Springer
Congenital adrenal hyperplasia (CAH) is a group of disorders affecting adrenal steroid
synthesis. The most common form, 21-hydroxylase deficiency, leads to decreased …

Treatment and health outcomes in adults with congenital adrenal hyperplasia

TS Han, BR Walker, W Arlt, RJ Ross - Nature Reviews Endocrinology, 2014 - nature.com
Congenital adrenal hyperplasia (CAH) is a genetic disorder caused by defective
steroidogenesis that results in glucocorticoid deficiency; the most common underlying …

Congenital adrenal hyperplasia: unresolved issues

M Yau, A Khattab, D Poppas, L Ghizzoni… - Cortisol Excess and …, 2016 - karger.com
Congenital adrenal hyperplasia (CAH) describes a family of disorders that comes from
enzymatic deficiencies in cortisol production, with 21-hydroxylase deficiency causing∼ 90 …

Congenital adrenal hyperplasia-experience from a tertiary centre in South India

G Belinda, D Vinay, J Moolechery… - Indian Journal of …, 2012 - journals.lww.com
Congenital adrenal hyperplasia is a group of autosomal recessive disorders caused by
enzyme deficiency which leads to defects in biosynthesis of steroid precursors. Most …

Management of the child with congenital adrenal hyperplasia

PC Hindmarsh - Best practice & research Clinical endocrinology & …, 2009 - Elsevier
Classical congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency leads to
glucocorticoid and mineralocorticoid deficiency. Management should be viewed as a …

Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

DP Merke - The Journal of Clinical Endocrinology & Metabolism, 2008 - academic.oup.com
Congenital adrenal hyperplasia (CAH) describes a group of autosomal recessive disorders
where there is impairment of cortisol biosynthesis. CAH due to 21-hydroxylase deficiency …

Prenatal and neonatal diagnosis and treatment of congenital adrenal hyperplasia

PW Speiser - Hormone Research, 2007 - karger.com
Background: Clinical management of patients with congenital adrenal hyperplasia (CAH)
involves treating hormonal deficiencies, addressing issues related to genital ambiguity …

Congenital adrenal hyperplasia: epidemiology, management and practical drug treatment

D Merke, M Kabbani - Paediatric Drugs, 2001 - Springer
Congenital adrenal hyperplasia (CAH) owing to 21-hydroxylase deficiency is a common
disorder, and is characterised by a defect in cortisol biosynthesis with or without a defect in …